Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,192Revenue (TTM) $M549Net Margin (%)8.7Altman Z-Score3.5
Enterprise Value $M1,158EPS (TTM) $1.0Operating Margin %9.1Piotroski F-Score4
P/E(ttm)29.4Beneish M-Score-2.6Pre-tax Margin (%)7.9Higher ROA y-yN
Price/Book2.210-y EBITDA Growth Rate %5.0Quick Ratio3.6Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %8.2Current Ratio4.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-36.4ROA % (ttm)4.7Higher Current Ratio y-yN
Dividend Yield %--PEG6.7ROE % (ttm)7.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M40.5ROIC % (ttm)5.7Gross Margin Increase y-yN

Gurus Latest Trades with EBS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EBSKen Fisher 2016-12-31 Reduce$24.6 - $35.88
($29.98)
$ 29.44-2%Reduce -7.84%418,270
EBSJoel Greenblatt 2016-09-30 Reduce-0.07%$26.41 - $31.9
($28.51)
$ 29.443%Reduce -47.88%242,516
EBSKen Fisher 2016-09-30 Reduce$26.41 - $31.9
($28.51)
$ 29.443%Reduce -2.97%453,870
EBSJoel Greenblatt 2016-06-30 Add0.01%$25.73 - $41.76
($36.98)
$ 29.44-20%Add 4.86%465,311
EBSKen Fisher 2016-06-30 Add$25.73 - $41.76
($36.98)
$ 29.44-20%Add 2.19%467,770
EBSJoel Greenblatt 2016-03-31 Reduce$29.88 - $37.78
($33.43)
$ 29.44-12%Reduce -0.70%443,728
EBSJoel Greenblatt 2015-12-31 Buy 0.19%$26.76 - $38.04
($33.14)
$ 29.44-11%New holding446,867
EBSKen Fisher 2015-12-31 Reduce$26.76 - $38.04
($33.02)
$ 29.44-11%Reduce -0.19%457,742
EBSKen Fisher 2015-09-30 Reduce$26.9 - $33.64
($31.15)
$ 29.44-5%Reduce -0.82%458,634
EBSKen Fisher 2015-06-30 Reduce$27.16 - $31.81
($29.24)
$ 29.441%Reduce -7.78%462,428
EBSJoel Greenblatt 2014-09-30 Sold Out -0.06%$20.12 - $23.51
($21.65)
$ 29.4436%Sold Out0
EBSJoel Greenblatt 2014-03-31 Buy 0.1%$21.58 - $26.53
($23.79)
$ 29.4424%New holding258,760
EBSJohn Rogers 2014-03-31 Sold Out -0.04%$21.58 - $26.53
($23.79)
$ 29.4424%Sold Out0
EBSJohn Rogers 2013-12-31 Add0.02%$16.72 - $22.62
($19.68)
$ 29.4450%Add 105.79%122,650
EBSJohn Rogers 2013-09-30 Add0.01%$14.37 - $18.35
($16.88)
$ 29.4474%Add 116.73%59,600
EBSJohn Rogers 2013-06-30 Buy 0.01%$12.35 - $14.85
($13.67)
$ 29.44115%New holding27,500
EBSJoel Greenblatt 2013-03-31 Sold Out -0.14%$13.17 - $15.96
($14.8)
$ 29.4499%Sold Out0
EBSJoel Greenblatt 2012-12-31 Buy 0.14%$12.19 - $15.19
($13.82)
$ 29.44113%New holding147,099
EBSKen Fisher 2012-12-31 Add$12.19 - $15.19
($13.82)
$ 29.44113%Add 21.09%401,700
EBSJoel Greenblatt 2011-12-31 Sold Out -0.08%$14.57 - $18.55
($16.44)
$ 29.4479%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EBS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


EBS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bailey SueDirector 2017-01-17Sell19,424$29.78-1.14view
Havey AdamEVP, Biodefense Divison 2017-01-17Sell8,438$29.75-1.04view
Abdun-Nabi DanielPresident and CEO 2017-01-10Sell28,240$31.28-5.88view
Richard RonaldDirector 2016-12-13Sell5,900$34.09-13.64view
JOULWAN GEORGE ADirector 2016-06-06Sell4,700$44.12-33.27view
Abdun-Nabi DanielPresident & CEO 2016-06-01Sell8,699$43.74-32.69view
El-Hibri FuadChairman, 10% Owner 2016-05-27Sell9,835$43.5-32.32view
El-Hibri FuadChairman, 10% Owner 2016-05-26Sell39,759$43.13-31.74view
El-Hibri FuadChairman, 10% Owner 2016-05-25Sell85,000$42.52-30.76view
Harsanyi ZsoltDirector 2016-05-25Sell27,867$42.33-30.45view

Press Releases about EBS :

Quarterly/Annual Reports about EBS:

News about EBS:

Articles On GuruFocus.com
Weekly CEO Sales Highlight: Realpage, Anadigics, Emergent BioSolutions, ScanSource Jan 03 2016 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) Nov 05 2010 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) Aug 06 2010 
Emergent BioSolutions Inc. (EBS) President & COO Daniel Abdun-nabi sells 18,150 Shares Jul 30 2010 
Weekly CEO Sells Highlight: Yum! Brands Inc, Marchex Inc, iGate Corp, and Emergent BioSolutions Inc. Jul 25 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 18,800 Shares Jul 23 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 130,100 Shares Jul 22 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 84,433 Shares Jul 19 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 52,000 Shares May 14 2010 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) May 06 2010 

More From Other Websites
Emergent BioSolutions, Inc. breached its 50 day moving average in a Bearish Manner : EBS-US :... Jan 12 2017
D.C.-area biotech stocks fall on Trump's tough talk on industry Jan 11 2017
Emergent Down on '17 View, Posts Preliminary '16 Results Jan 10 2017
EMERGENT BIOSOLUTIONS INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 09 2017
Emergent BioSolutions Announces Preliminary 2016 Financial Results and Provides 2017 Financial... Jan 09 2017
People and Prosperity Financial resolutions for 2017: Austrians want to be more disciplined in the... Jan 04 2017
Soligenix Announces Extension of Development Agreement with Emergent BioSolutions Jan 03 2017
Emergent BioSolutions to Participate in First Quarter 2017 Investor Conferences Dec 29 2016
Emergent BioSolutions to Participate in First Quarter 2017 Investor Conferences Dec 29 2016
Is Consolidated Communications Holdings Inc (CNSL) A Good Stock To Buy? Dec 16 2016
Technical-analysis trading: Four stocks that may be moving higher Dec 15 2016
Four Stocks Moving Higher Dec 14 2016
Hedge Funds Are Dumping Emergent Biosolutions Inc (EBS) Dec 14 2016
Why stock in this Gaithersburg biotech is up more than 25 percent Dec 14 2016
Emergent BioSolutions, Inc. – Value Analysis (NYSE:EBS) : December 13, 2016 Dec 13 2016
Emergent BioSolutions, Inc.: Gathering momentum, can it sustain its performance? Dec 12 2016
Emergent BioSolutions (EBS) in Focus: Stock Rises 18.9% Dec 12 2016
Emergent BioSolutions, Inc. breached its 50 day moving average in a Bullish Manner : EBS-US :... Dec 12 2016
Emergent BioSolutions Receives Health Canada Approval for Botulism Antitoxin Dec 12 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)